| Nome |
# |
|
Malattia renale cronica e sindrome coronarica acuta : il ruolo della troponina = Troponins and chronic kidney disease, file dfa8b992-d5b8-748b-e053-3a05fe0a3a96
|
577
|
|
Cardiac valve calcification : an immutable pathologic finding in chronic kidney disease?, file dfa8b990-a362-748b-e053-3a05fe0a3a96
|
356
|
|
Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction, file dfa8b990-f14b-748b-e053-3a05fe0a3a96
|
341
|
|
Vascular calcification in chronic kidney disease : an update, file dfa8b990-e846-748b-e053-3a05fe0a3a96
|
329
|
|
Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), coinvolgimento cardiovascolare e prognosi, file dfa8b998-ac22-748b-e053-3a05fe0a3a96
|
284
|
|
Il trattamento del diabete mellito di tipo 2 nei pazienti affetti da malattia renale cronica: cosa aspettarsi dai nuovi ipoglicemizzanti orali, file dfa8b997-7de8-748b-e053-3a05fe0a3a96
|
267
|
|
THE IMPACT OF PHOSPHOROUS CONTROL IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS, file dfa8b993-8a34-748b-e053-3a05fe0a3a96
|
197
|
|
I nuovi Anti-Coagulanti Orali (NOAC) : cosa deve sapere un Nefrologo = New oral anticoagulants (NOAC) in nephrology, file dfa8b996-07b8-748b-e053-3a05fe0a3a96
|
171
|
|
Which vitamin D in CKD-MBD? The time of burning questions, file dfa8b990-c608-748b-e053-3a05fe0a3a96
|
142
|
|
Ivabradine, heart failure and chronic kidney disease, file dfa8b994-941b-748b-e053-3a05fe0a3a96
|
112
|
|
Treatment of secondary hyperparathyroidism : the clinical utility of etelcalcetide, file dfa8b998-99d4-748b-e053-3a05fe0a3a96
|
108
|
|
Single-center open-label randomized study of anemia management improvement in ESRD patients with secondary hyperparathyroidism, file dfa8b995-890f-748b-e053-3a05fe0a3a96
|
107
|
|
The evolving world of chronic kidney disease mineral bone disorder, file dfa8b990-ea57-748b-e053-3a05fe0a3a96
|
100
|
|
Correction of metabolic acidosis improves insulin resistance in chronic kidney disease, file dfa8b996-8852-748b-e053-3a05fe0a3a96
|
95
|
|
At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy, file dfa8b9a5-7d06-748b-e053-3a05fe0a3a96
|
88
|
|
Nuove acquisizioni nella patogenesi dell'iperparatiroidismo secondario = New insights in the pathogenesis of secondary hyperparathyroidism, file dfa8b9a1-213b-748b-e053-3a05fe0a3a96
|
82
|
|
Pulmonary embolism in patients with COVID‑19: characteristics and outcomes in the Cardio‑COVID Italy multicenter study, file dfa8b9a4-0958-748b-e053-3a05fe0a3a96
|
59
|
|
Anticoagulanti orali non vitamina K dipendenti (NOACs) nei pazienti affetti da malattia renale cronica e fibrillazione atriale non valvolare, file dfa8b998-c91c-748b-e053-3a05fe0a3a96
|
52
|
|
Effetti della dose degli agenti stimolanti l'eritropoiesi su esiti cardio-cerebrovascolari, qualita di vita e costi in emodialisi, file dfa8b991-b5eb-748b-e053-3a05fe0a3a96
|
48
|
|
L’inibizione del sistema renina-angiotensina è un trattamento utile nei pazienti con Nefropatia HIV albuminurica?, file dfa8b991-0a3b-748b-e053-3a05fe0a3a96
|
34
|
|
The prognostic value of serial troponin measurements in patients admitted for COVID-19, file dfa8b9a7-7eb1-748b-e053-3a05fe0a3a96
|
31
|
|
L’Accademia delle idee : iniziativa dei giovani per i giovani. Contenitore di progetti innovativi?, file dfa8b9a1-213c-748b-e053-3a05fe0a3a96
|
8
|
|
[Ozone therapy: a potential adjunct approach to lower urinary tract infection? A case series report], file dfa8b990-f975-748b-e053-3a05fe0a3a96
|
7
|
|
Metodiche di immagine per valutare la progressione della placca aterosclerotica, file dfa8b991-aff6-748b-e053-3a05fe0a3a96
|
7
|
|
Calcifediol to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease, file dfa8b999-1f8b-748b-e053-3a05fe0a3a96
|
7
|
|
Sudden cardiac death and chronic kidney disease : from pathophysiology to treatment strategies, file dfa8b995-977e-748b-e053-3a05fe0a3a96
|
5
|
|
Opponent's comments, file dfa8b994-e0f4-748b-e053-3a05fe0a3a96
|
4
|
|
Opponent's comments, file dfa8b995-3e3f-748b-e053-3a05fe0a3a96
|
4
|
|
Does it make sense to measure only the brachial blood pressure?, file dfa8b990-f973-748b-e053-3a05fe0a3a96
|
3
|
|
Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease, file dfa8b991-0ee5-748b-e053-3a05fe0a3a96
|
3
|
|
Management of secondary hyperparathyroidism in uremic patients : the role of the new vitamin D analogs, file dfa8b991-fe96-748b-e053-3a05fe0a3a96
|
3
|
|
Uric Acid in chronic kidney disease : a clinical appraisal, file dfa8b995-8e7c-748b-e053-3a05fe0a3a96
|
3
|
|
Calcificazioni coronariche nei pazienti affetti da diabete mellito, file dfa8b990-e028-748b-e053-3a05fe0a3a96
|
2
|
|
Salvage insertion of tunneled central venous catheters in the internal jugular vein after accidental catheter removal, file dfa8b992-145d-748b-e053-3a05fe0a3a96
|
2
|
|
Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy, file dfa8b995-6e57-748b-e053-3a05fe0a3a96
|
2
|
|
Chelanti del fosforo a base di ferro : quali nuovi vantaggi? = Iron-based Phosphate Binders for ESRD Patients, file dfa8b996-07b7-748b-e053-3a05fe0a3a96
|
2
|
|
Cinacalcet but not vitamin D use modulates the survival benefit associated with sevelamer in the INDEPENDENT study, file dfa8b997-01f7-748b-e053-3a05fe0a3a96
|
2
|
|
Pulmonary embolism in patients with COVID‑19: characteristics and outcomes in the Cardio‑COVID Italy multicenter study, file dfa8b9a9-fd94-748b-e053-3a05fe0a3a96
|
2
|
|
Integration of clinical and imaging data to predict death in hemodialysis patients, file dfa8b991-c3e3-748b-e053-3a05fe0a3a96
|
1
|
|
Vitamin D status and coronary flow reserve measured by positron emission tomography : a co-twin control study, file dfa8b991-d02e-748b-e053-3a05fe0a3a96
|
1
|
|
Emerging drugs for secondary hyperparathyroidism, file dfa8b992-00ec-748b-e053-3a05fe0a3a96
|
1
|
|
New insights into ischemic heart disease in women, file dfa8b992-02a5-748b-e053-3a05fe0a3a96
|
1
|
|
[Penultimate pulse wave velocity, better than baseline pulse wave velocity, predicted mortality in italian ESRD cohort study - a case for daily hemodialysis for ESRD patients with accelerated pulse wave velocity changes], file dfa8b992-02a8-748b-e053-3a05fe0a3a96
|
1
|
|
Serum calcium may not accurately predict intradialytic calcium mass transfer, file dfa8b994-cd24-748b-e053-3a05fe0a3a96
|
1
|
|
Vascular calcification, bone and mineral metabolism after kidney transplantation, file dfa8b994-cd27-748b-e053-3a05fe0a3a96
|
1
|
|
Vascular and valvular calcifications in chronic kidney disease : an update, file dfa8b995-8e7b-748b-e053-3a05fe0a3a96
|
1
|
|
The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents, file dfa8b998-10db-748b-e053-3a05fe0a3a96
|
1
|
|
Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation, file dfa8b998-3eb7-748b-e053-3a05fe0a3a96
|
1
|
|
Gli anticoagulanti orali non vitamina K-dipendenti nei pazienti con fibrillazione atriale non valvolare ed end-stage renale disease (ESRD): un matrimonio impossibile?, file dfa8b998-9c53-748b-e053-3a05fe0a3a96
|
1
|
|
Pathophysiology of the Cardiorenal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI), file dfa8b999-2d91-748b-e053-3a05fe0a3a96
|
1
|
|
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study), file dfa8b9aa-05c1-748b-e053-3a05fe0a3a96
|
1
|
| Totale |
3659 |